# ART Drug Dosage Adjustment in HIV-infected Population

> **NCT02632474** · PHASE4 · COMPLETED · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 10 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Tenofovir(TDF)+Lamivudine(3TC)+Efavirenz(EFV)

## Key facts

- **NCT ID:** NCT02632474
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632474, "ART Drug Dosage Adjustment in HIV-infected Population". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02632474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*